Content Block Tag: NRG-CC013: Managing Symptoms of Oral Anti-Cancer Treatment

‘Text/HTML’ of page ‘NRG-CC013: Managing Symptoms of Oral Anti-Cancer Treatment’

Am I eligible for this study? People with head and neck cancer that will be receiving the usual treatment of cisplatin chemotherapy and radiation therapy may be eligible for the study. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to […]

‘Text/HTML’ of page ‘NRG-CC013: Managing Symptoms of Oral Anti-Cancer Treatment’

About This Study NRG-CC013 is a clinical study that will test whether adding the drug BMX-001 to the usual cisplatin chemotherapy and radiation therapy reduces inflammation and mouth sores when compared to cisplatin chemotherapy and radiation therapy alone. Typically, people with head and neck cancer are treated with cisplatin chemotherapy and radiation therapy, which […]

‘Text/HTML’ of page ‘NRG-CC013: Managing Symptoms of Oral Anti-Cancer Treatment’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-CC013: Managing Symptoms of Oral Anti-Cancer Treatment’

The NRG-CC013 Study FAQ